Glanbia Nutritionals has added OmniMEGA Advanced Omega-3 Powder to its proprietary ingredient portfolio. OmniMEGA is a patented, free-flowing omega-3 powder, offering the ability to formulate into multi-ingredient tablet, capsule, melt and powdered beverage applications. 

OmniMEGA’s enhanced composition provides solutions for issues with auto-oxidation, limited shelf-life, sensitivities to air, heat, light and humidity, and the potential to cause “fish-burps.” OmniMEGA is comprised of omega-3 fatty acids from fish oil that are bound to a beta cyclodextrin backbone making a compressible powder suitable for tableting and ready-to-mix formulations that is more shelf stable, with less sensitivity to air and oxidation, without the fishy reflux. OmniMEGA is also GRAS and holds two process patents.

OmniMEGA studies have shown positive results in many areas with a bioavailability human clinical study showing that OmniMEGA tablets offer superior EPA and DHA absorption compared to soft-gels. In long-term accelerated stability studies OmniMEGA powder was shown to have excellent stability and shelf-life. Three unique studies assessed the occurrence of reflux 8-24 hours after consuming OmniMEGA tablets compared to omega-3 soft-gel capsules with the results showing no reflux occurring from consumption of OmniMEGA tablets.

“The addition of OmniMEGA Advanced Omega-3 Powder to Glanbia Nutritionals’ portfolio of premier ingredients provides customers the ability to formulate an omega-3 in to a powdered multi-ingredient application such as direct compressible tablets, capsules, ready-to-mix powdered beverages for sports nutrition and rapid melts as an alternative to children’s gummies. OmniMEGA further expands the innovative ingredient options Glanbia Nutritionals offers for inclusion in supplements,” said Ram Nimmagudda, PhD, director of business development for Glanbia Nutritionals.